Cargando…
The utility of dupilumab for use in the pediatric population
Autores principales: | Varma, Aakaash, Tassavor, Michael, Levitt, Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827273/ https://www.ncbi.nlm.nih.gov/pubmed/31700963 http://dx.doi.org/10.1016/j.jdcr.2019.08.023 |
Ejemplares similares
Ejemplares similares
-
Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis
por: Varma, Aakaash, et al.
Publicado: (2020) -
Did dupilumab unmask smoldering mycosis fungoides?
por: Toker, Michelle, et al.
Publicado: (2023) -
Letter in response to the case report: “Recalcitrant generalized granuloma annulare treated successfully with dupilumab”
por: Paganini, Claudia, et al.
Publicado: (2023) -
Treatment of chronic bullous disease of childhood with dupilumab after dapsone-induced methemoglobinemia in a 2-year-old female patient
por: Yousefian, Faraz, et al.
Publicado: (2023) -
Resolution of pretibial myxedema with teprotumumab in a patient with Graves disease
por: Varma, Aakaash, et al.
Publicado: (2020)